2013
Symptomatic Obstruction of the Brachiocephalic and Left Subclavian Arteries Obscured by Aortic Stenosis
Hashim PW, Assi R, Grecu L, Dardik A. Symptomatic Obstruction of the Brachiocephalic and Left Subclavian Arteries Obscured by Aortic Stenosis. Annals Of Vascular Surgery 2013, 28: 737.e1-737.e5. PMID: 24368183, DOI: 10.1016/j.avsg.2013.04.030.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAgedAngioplasty, BalloonAortic Valve StenosisArterial Occlusive DiseasesBrachiocephalic TrunkConstriction, PathologicDiagnostic ErrorsDizzinessFemaleHeart Valve Prosthesis ImplantationHemodynamicsHumansMuscle WeaknessPredictive Value of TestsStentsSubclavian Steal SyndromeSyncopeTreatment OutcomeUltrasonography, Doppler, ColorConceptsAortic stenosisLeft-sided weaknessAortic valve replacementArtery obstructionUncommon causeValve replacementSubclavian arterySymptomatic reliefCerebrovascular insufficiencyPatient's symptomsBrachiocephalic trunkClinical manifestationsSymptomatic obstructionVessel diseaseBrachiocephalic arteryDiagnostic challengeSubclavian obstructionUpper extremityStenosisObstructionBrachiocephalicArterySymptomsLightheadednessStenting
2005
Sirolimus-Eluting versus Bare Nitinol Stent for Obstructive Superficial Femoral Artery Disease: The SIROCCO II Trial
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP. Sirolimus-Eluting versus Bare Nitinol Stent for Obstructive Superficial Femoral Artery Disease: The SIROCCO II Trial. Journal Of Vascular And Interventional Radiology 2005, 16: 331-338. PMID: 15758128, DOI: 10.1097/01.rvi.0000151260.74519.ca.Peer-Reviewed Original ResearchConceptsSirolimus-eluting stent groupStent groupBare stent groupMean lumen diameterSignificant differencesLumen diameterSuperficial femoral artery diseaseSuperficial femoral artery obstructionChronic limb ischemiaFemoral artery diseaseFemoral artery obstructionAnkle-brachial indexBinary restenosis rateDouble-blind studySymptoms of claudicationBare nitinol stentsSirolimus-eluting stentsStandard interventional techniquesArtery obstructionPrimary endpointII trialAdverse eventsAngiographic outcomesArtery diseaseLimb ischemia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply